26.20

4.09% 1.03

Spyglass Pharma Inc (SGP)

Overview News Price History Discussions Forecast

Spyglass Pharma Inc stock is traded at $26.20, with a volume of 69,689. It is up +4.09% in the last 24 hours and up +31.07% over the past month. SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.

Previous Close:

$25.17

Open:

$26.01

24h Volume:

69,689

Relative Volume:

0.64

Market Cap:

$876.34M

Revenue:

Net Income/Loss:

P/E Ratio:

-4.9533

EPS:

-5.2894

Net Cash Flow:

1W Performance:

+3.52%

1M Performance:

+31.07%

6M Performance:

-7.16%

1Y Performance:

+0.00%

1-Day Range:

$25.09

$26.44

1-Week Range:

$24.43

$26.44

52-Week Range:

$17.06

$30.56

Spyglass Pharma Inc Stock (SGP) Company Profile

Name

Spyglass Pharma Inc

Sector

Healthcare (1080)

Industry

Biotechnology (604)

Phone

949-284-6904

Address

27081 ALISO CREEK ROAD, ALISO VIEJO

Employee

Twitter

Next Earnings Date

2026-08-13

Latest SEC Filings

SGP's Discussions on Twitter

Compare SGP vs VRTX, REGN, ARGX, RVMD, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SGP Spyglass Pharma Inc	26.20	845.23M	0	0	0	-5.2894
VRTX Vertex Pharmaceuticals Inc	505.75	133.25B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	803.48	82.16B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	851.29	54.80B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	203.71	43.99B	742.00K	-1.37B	-1.07B	-7.0731
ONC Beone Medicines Ltd Adr	347.48	40.62B	5.76B	514.49M	1.10B	4.4813

Spyglass Pharma Inc Stock (SGP) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-10-26	Initiated	H.C. Wainwright	Buy
Mar-03-26	Initiated	Citigroup	Buy
Mar-03-26	Initiated	Jefferies	Buy
Mar-03-26	Initiated	Leerink Partners	Outperform
Mar-03-26	Initiated	Stifel	Buy

Spyglass Pharma Inc Stock (SGP) Latest News

Aug 14, 2026

SpyGlass Pharma, Inc. (NASDAQ: SGP) Share Price, SGP Stock News, SGP Share Price & Updates - Kalkine

Aug 14, 2026

Spyglass Pharma (SGP) Insider Trading Activity 2026 $SGP - MarketBeat

Aug 14, 2026

Raymond James initiates SpyGlass Pharma stock coverage with outperform rating - Investing.com

Aug 14, 2026

Aug 11, 2026

Q3 EPS Estimates for Spyglass Pharma Decreased by Analyst - MarketBeat

Aug 11, 2026

SpyGlass Pharma Reports Q2 Financials, Provides Corporate Updates - VisionMonday.com

Aug 11, 2026

Aug 07, 2026

Spyglass Pharma, Inc. (NASDAQ:SGP) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Aug 07, 2026

Aug 06, 2026

SpyGlass Pharma 2Q 2026: Net loss $(19.9)M, EPS $(0.59) — 10-Q Summary - TradingView

Aug 06, 2026

[10-Q] SpyGlass Pharma, Inc. Quarterly Earnings Report - Stock Titan

Aug 06, 2026

SpyGlass Pharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 06, 2026

SpyGlass Pharma reports $19.9M Q2 net loss, $234.2M cash and investments as of June 30, 2026 - TradingView

Aug 06, 2026

SpyGlass Pharma Q2 net loss widens on higher expenses - TradingView

Aug 06, 2026

SpyGlass Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Updates - Yahoo Finance

Aug 06, 2026

SpyGlass Pharma Insiders Enjoying US$1.1m Appreciation On US$2.16m Investment - webull.com

Aug 06, 2026

SpyGlass Pharma (SGP) Rallies 3.08% to $24.41 as Ophthalmic Focus Draws Fresh BuyingLow Vol Factor - dars.gov.et

Aug 06, 2026

SpyGlass Pharma Ord shs (Proposed) (SGP) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com

Aug 06, 2026

Aug 04, 2026

22,536,164 Common Stock of SpyGlass Pharma, Inc. are subject to a Lock-Up Agreement Ending on 5-AUG-2026. - marketscreener.com

Aug 04, 2026

Jul 25, 2026

SpyGlass Pharma (SGP) Jefferies Global Healthcare Conference 2026 Summary - Quartr

Jul 22, 2026

Jul 20, 2026

Top Spyglass Pharma (SGP) Competitors 2026 - MarketBeat

Jul 20, 2026

Jul 18, 2026

SpyGlass Pharma (SGP) Drops 4.77% as Key Support Levels Are TestedFade Trade - dars.gov.et

Jul 18, 2026

SpyGlass Pharma (SGP) Dips Nearly 5%, Testing Key Support LevelsFundamentals - dars.gov.et

Jul 18, 2026

Jul 10, 2026

SpyGlass Pharma (SGP) Rallies 2.67%, Tests Key Resistance LevelDynamic Hedging - dars.gov.et

Jul 10, 2026

Jul 09, 2026

SGP Q1 2026 Earnings: EPS Misses Estimates as Revenue Remains AbsentEarnings Miss Alert - dars.gov.et

Jul 09, 2026

Jul 02, 2026